Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European Stocks Mainly Lower; FTSE 100 Outperforms After U.K. Vaccine News

Published 12/02/2020, 04:02 AM
Updated 12/02/2020, 04:03 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets traded largely lower Wednesday, although hopes for more U.S. fiscal stimulus as well as Covid-19 vaccine expectations continue to provide support.

At 4:05 AM ET (0905 GMT), the DAX in Germany traded 0.4% lower, the CAC 40 in France fell 0.3%, while the U.K.'s FTSE index outperformed, climbing 0.1%. These indices posted strong gains Tuesday, the first day of December, continuing the previous month’s sharp move higher.

In Europe, British regulators approved Wednesday the Pfizer/BioNTech vaccine for use, with distribution beginning next week. This positive news is likely to be duplicated in the European Union shortly, with this vaccine, as well as Moderna’s, already in front of the European regulator. 

German retail sales rebounded in October, climbing 2.6% on the month, while negotiators from both the European Union and Britain tried to strike a post-Brexit trade deal before the end of the week.

In corporate news, G4S (LON:GFS) stock rose 7.5% after Canada's GardaWorld increased its offer for the British security services company to 235 pence a share from 190p, now valuing it at 3.68 billion pounds ($4.92 billion).

On the flip side, office provider IWG (LON:IWG) fell 7.7% after launching a 300 million pound convertible bond offering.

A bipartisan group of U.S. lawmakers unveiled a $908 billion stimulus plan on Tuesday. Although Senate Majority Leader Mitch McConnell quickly killed the proposal, the fact a new plan is back on the table has investors hopeful for a new package in the near future.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Oil prices were mixed Wednesday, amid uncertainty over whether a group of leading producers will maintain current supply levels going into the new year.

Industry data from the American Petroleum Institute late Tuesday showed U.S. crude inventories rose by 4.1 million barrels last week, compared with expectations for a draw of 2.3 million barrels. Official data are due later in Wednesday’s session.

This release emerged after OPEC and its allies, a group known as OPEC+, had postponed to Thursday a decision over the level of next year’s supply, raising concerns that pressure is growing within the group to raise output despite the current weak overall demand. 

U.S. crude futures traded 0.1% lower at $44.52 a barrel, while the international benchmark Brent contract fell 0.1% to $47.45. 

Elsewhere, gold futures rose 0.5% to $1,828.15/oz, while EUR/USD traded 0.2% lower at 1.2051.



 

 

Latest comments

Pfizer doing their LD50 tests in Brexit Britain, ***yeah we're open for business
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.